Egetis Therapeutics AB's total assets for Q4 2025 were kr639.10M, an increase of 7.39% from the previous quarter. SE:EGTX total liabilities were kr300.40M for the fiscal quarter, a -5.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.